Santhera Pharmaceuticals Holding AG Cash Flow Quality Index
Santhera Pharmaceuticals Holding AG cash flow quality index. Santhera Pharmaceuticals Holding AG (SANN) has a Cash Flow Quality Index of 0.80x as of December 2023. Operating cash flow of CHF62.63 Million is below net income of CHF78.12 Million, suggesting accrual-heavy earnings not yet converted to cash. See Santhera Pharmaceuticals Holding AG financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Santhera Pharmaceuticals Holding AG (2009–2023)
Cash flow quality index of Santhera Pharmaceuticals Holding AG from 2009 to 2023. Historical Cash Flow Quality Index for Santhera Pharmaceuticals Holding AG across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Santhera Pharmaceuticals Holding AG cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Santhera Pharmaceuticals Holding AG Cash Flow Quality Index by Year (2009–2023)
Santhera Pharmaceuticals Holding AG cash flow quality index by year from 2009 to 2023. Year-by-year earnings quality comparison for Santhera Pharmaceuticals Holding AG. For the full cash flow conversion analysis, see Santhera Pharmaceuticals Holding AG operating cash flow efficiency.
| Year | Quality Index | Operating CF (CHF) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.86x | CHF47.27 Million | CHF54.78 Million | ▲ +111.3% |
| 2015 | -7.63x | CHF-22.39 Million | CHF2.93 Million | ▼ -853.2% |
| 2009 | -0.80x | CHF-20.75 Million | CHF25.92 Million | — |